What the research found

Researchers used continuous glucose monitoring to track 23 experienced Jain fasters undertaking water-only fasts lasting 8–30 days. Blood work and mood assessments were collected at baseline, around day 9, and 60 days after fasting ended. The key finding was metabolic stability: glucose variability essentially disappeared within the first day or two and remained flat throughout, with no episodes of dangerously low blood sugar despite complete caloric absence.

Blood chemistry showed a predictable acute stress response during the fast—rises in liver enzymes, bilirubin, uric acid, and creatinine—but these markers recovered to baseline or better by the 60-day follow-up. Notably, inflammatory marker (hsCRP) declined below starting levels after recovery, and both HDL and LDL improved durably. Thyroid hormone suppression, common during prolonged fasting, fully normalized by follow-up. Mood and psychological wellbeing remained stable throughout.

Why it matters for you

If you're experimenting with extended fasting protocols, this offers real-world evidence that the body can sustain 30+ days of zero caloric intake without acute metabolic crisis. The absence of hypoglycaemia—confirmed by continuous monitoring rather than finger-stick snapshots—suggests that once fat-adapted, the liver's ketone output stabilizes blood glucose reliably. This matters if you're designing longer fasts and want to understand what "normal" physiology looks like rather than relying on anecdotal reports.

The transient elevation in liver enzymes and creatinine during the fast is worth noting: these aren't pathological in the short term, but they do indicate physiological stress. If you track bloodwork during fasting windows, expect these to spike and recover. The durable improvement in hsCRP and lipid ratios after recovery is encouraging for cardiometabolic health markers you likely monitor.

One practical caveat: these participants were experienced practitioners—their bodies were adapted to fasting culturally and physiologically. The findings don't necessarily predict outcomes in people attempting extended fasts for the first time.

Caveats

  • Self-selected cohort: Participants were experienced Jain fasters with prior conditioning; generalizability to naive fasters unknown.
  • Small sample and uncontrolled: No control arm; within-participant comparisons only.
  • Observational design: No blinding, no randomization.
  • Biomarker interpretation: Transient liver enzyme elevation is documented but clinical significance during fasting remains unclear.
  • Follow-up duration: 60-day follow-up is short; longer-term consequences not assessed.
  • Spiritual context: Fasting was spiritually motivated; psychological factors may have buffered stress responses.